The antidepressant sertraline downregulates Akt and has activity against melanoma cells
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Melanoma is a common malignancy which is poorly responsive to chemotherapy and radiation. One of the major reasons melanoma responds poorly to these modalities is constitutive expression of Akt, which protects against apoptosis. The antidepressant sertraline was found to be a potent cytotoxic agent against A375 human melanoma. To determine the mechanism by which sertraline kills melanoma cells, Western blot analysis of signaling molecules, including phosphorylated Akt, caspase 9 and phospho‐p70 S6 kinase was performed. Finally, the effects of sertraline on A375 xenografts in mice were assessed. Sertaline potently inhibited the phosphorylation of Akt, and caused cell death through induction of endoplasmic reticulum in vitro. Sertraline monotherapy demonstrated activity against A375 xenografts in vivo. Akt is a major cause of resistance of melanoma to current therapy. Antidepressants are commonly used to prevent interferon‐induced depression. Use of antidepressants that decrease Akt may improve the efficacy of interferon and other therapies against melanoma. Further studies are needed to elucidate whether sertraline acts as an Akt inhibitor in melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · cited 2×
“Indeed, the major switch of melanocyte-specific transcrip- tion, microopthalmia, is amplified in a subset of human melanoma (Garraway et al., 2005).”
BackgroundParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“…autoimmune or 454 ª 2008 The Authors, Journal Compilation ª 2008 Blackwell Munksgaard malignant disorders experience depression due to the interferon (Musselman et al., 2001), our study provides a rationale for clinical trials of interferon plus antidepres- sants for solid tumors such as…”
BackgroundNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Self-citationGovindarajan, B., Klafter, R., Miller, M. S., Mansur, C., Mizesko, M., Bai, X., LaMontagne, K., & Arbiser, J. L. (2002) · Molecular Medicine · doi:10.1007/bf03401997 · Cited by 145 · cited 1×
“…reactive oxygen species (ROS) are known participants in melanoma signaling pathways, and are involved in all three steps (initiation, promotion and progression) of carcinogenesis (Arbiser et al., 2002b; Govindarajan et al., 2002, 2007; Sung et al., 2006), we studied the effect of sertraline on ROS.”
BackgroundSelf-citationAberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes
Meyskens, F. L., McNulty, S. E., Buckmeier, J. A., Tohidian, N. B., Spillane, T. J., Kahlon, R. S., & Gonzalez, R. I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00650-5 · Cited by 126
Cited by
GSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84
Chen, S., Xuan, J., Wan, L., Lin, H., Couch, L., Mei, N., Dobrovolsky, V. N., & Guo, L. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft254 · Cited by 75
Radin, D. P., & Patel, P. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.024 · Cited by 32
Metadata
- Authors
- Reddy, K. K., Lefkove, B., Chen, L. B., Govindarajan, B., Carracedo, A., Velasco, G., Carrillo, C. O., Bhandarkar, S. S., Owens, M. J., Mechta‐Grigoriou, F., & Arbiser, J. L.
- Venue
- Pigment Cell & Melanoma Research
- Publisher
- Wiley
- Published
- 2008-07-11
- Volume
- 21
- Issue
- 4
- Pages
- 451-456
- ISSN
- 1755-1471 (ISSN-L)
- 1755-148X
- OpenAlex
- W2082175409
- Cited by
- 78
- References
- 5
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The antidepressant sertraline downregulates Akt and has activity against melanoma cells. https://app.cochat.ai/papers/10.1111/j.1755-148x.2008.00481.x
- The paper
- Reddy, K. K., Lefkove, B., Chen, L. B., Govindarajan, B., Carracedo, A., Velasco, G., Carrillo, C. O., Bhandarkar, S. S., Owens, M. J., Mechta‐Grigoriou, F., & Arbiser, J. L. (2008). The antidepressant sertraline downregulates Akt and has activity against melanoma cells. Pigment Cell & Melanoma Research. https://doi.org/10.1111/j.1755-148x.2008.00481.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.